Morgan Stanley
COYA icon

Morgan Stanley’s Coya Therapeutics COYA Stock Holding History

Morgan Stanley’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Sell
82,106
-3,594
-4% -$16.6K ﹤0.01% 5575
2026
Q1 		$338K Buy
85,700
+32,344
+61% +$151K ﹤0.01% 5662
2025
Q4 		$309K Buy
53,356
+51,831
+3,399% +$315K ﹤0.01% 5742
2025
Q3 		$8.69K Buy
1,525
+725
+91% +$4.41K ﹤0.01% 6943
2025
Q2 		$4.6K Sell
800
-5,940
-88% -$34.4K ﹤0.01% 7059
2025
Q1 		$43.6K Buy
6,740
+3,940
+141% +$24.9K ﹤0.01% 6318
2024
Q4 		$16K Buy
2,800
+2,000
+250% +$13.6K ﹤0.01% 6641
2024
Q3 		$5.16K Hold
800
– – ﹤0.01% 6911
2024
Q2 		$4.85K Buy
800
+268
+50% +$2.15K ﹤0.01% 6859
2024
Q1 		$5.28K Buy
532
+32
+6% +$251 ﹤0.01% 6880
2023
Q4 		$3.71K Sell
500
-1
-0.2% -$6 ﹤0.01% 6903
2023
Q3 		$1.92K Buy
501
+301
+151% +$1.2K ﹤0.01% 7140
2023
Q2 		$814 Buy
+200
New +$928 ﹤0.01% 7327

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Morgan Stanley's COYA Position: Q2 2026 in Review

Morgan Stanley reduced its Coya Therapeutics (COYA) stake by 4.2% in Q2 2026, selling an estimated $16.6K and leaving 82,106 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #5575.

Morgan Stanley first reported a position in COYA in Q2 2023 and has held it in 13 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Morgan Stanley held 82,106 shares of Coya Therapeutics worth $480K as of Q2 2026.
  • Morgan Stanley sold 3,594 Coya Therapeutics shares in Q2 2026, an estimated $16.6K.
  • Coya Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5575 holding.
  • Morgan Stanley first reported a position in Coya Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.